Clinical Faculty

Bijay Prabhakaran Nair, M.D.

Assistant Professor of Medicine

M.D., University of Kerala, India
M.P.H., University of Minnesota
Residency, Internal Medicine, University of Arkansas for Medical Sciences
Fellowship,Hematology/Oncology, University of Arkansas for Medical Sciences

Selected Publications:

Nair B, Raval G, Mehta P. TNF-α inhibitor etanercept and hematologic malignancies: report of a case and review of the literature.  American Journal of Hematology. 2007 Jul 24;82(11):1022-1024

Bijay Nair, Frits van Rhee, John D Shaughnessy, Jr, Elias Anaissie, Jackie Szymonifka, Antje Hoering, Yazan Alsayed, Sarah Waheed, John Crowley, and Bart Barlogie
Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with bortezomib, lenalidomide and dexamethasone (VRD) maintenance
Blood, Feb 2010; doi:10.1182/blood-2009-11-25562

Nair B, Shaughnessy JD Jr, Zhou Y, Astrid-Cartron M, Qu P, van Rhee F, Anaissie E, Alsayed Y, Waheed S, Hollmig K, Szymonifka J,
Petty N, Hoering A, Barlogie B.
Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival. Blood. 2009;113:6572–6575. PMID: 19389881.

About Multiple Myeloma // About the Myeloma Institute // Becoming a Patient
Highlights of Our Myeloma Program  // Our Physician Team // Our Nursing Team
News/Events/Press Releases // Scientific Publications/Research
About Little Rock & Arkansas // About UAMS // About The Winthrop P. Rockefeller Cancer Institute
Travel/Directions/Maps // Contact Us // Make a Donation

Having problems with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
Terms and Conditions of Use

The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites.